Walgreens Boots Alliance, Inc. (WBA) Financials
WBA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-02-29 | 84.2 billion | 68.8 billion |
2023-11-30 | 97.8 billion | 70.1 billion |
2023-08-31 | 96.6 billion | 68.1 billion |
2023-05-31 | 98.6 billion | 69.1 billion |
WBA Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-02-29 | -989.0 million | 48.0 million |
2023-11-30 | -787.0 million | 51.0 million |
2023-08-31 | 555.0 million | 37.0 million |
2023-05-31 | -545.0 million | 55.0 million |
WBA Net Income
Date | Net Income |
---|---|
2024-02-29 | -5.9 billion |
2023-11-30 | -278.0 million |
2023-08-31 | -208.0 million |
2023-05-31 | -48.0 million |
WBA Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-02-29 | 668.0 million | - | 24.2 billion |
2023-11-30 | 784.0 million | - | 24.5 billion |
2023-08-31 | 739.0 million | - | 24.5 billion |
2023-05-31 | 970.0 million | 8.8 billion | 24.5 billion |
WBA Shares Outstanding
WBA Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-02-29 | 352.0 million | - | 7.9 billion | - |
2023-11-30 | 506.0 million | - | 6.9 billion | - |
2023-08-31 | 484.0 million | 371.0 million | 6.2 billion | 775.0 million |
2023-05-31 | 525.0 million | - | 7.1 billion | - |
WBA Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-02-29 | 37.1 billion | 30.6 billion |
2023-11-30 | 36.7 billion | 29.9 billion |
2023-08-31 | 35.4 billion | 28.9 billion |
2023-05-31 | 35.4 billion | 28.8 billion |
WBA
Price: $17.64
Dividend Yield: 0.10%
Forward Dividend Yield: 5.54%
Payout Ratio: 151.52%
Dividend Per Share: 1.00 USD
Earnings Per Share: 0.66 USD
P/E Ratio: 33.58
Exchange: NMS
Sector: Healthcare
Industry: Pharmaceutical Retailers
Volume: 5.5 million
Ebitda: 1.7 billionMarket Capitalization: 15.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 40
DGR3: 1.58%
DGR5: 3.53%
DGR10: 5.35%
DGR20: 11.69%